Furthermore, TUBA1C is positively correlated with the TMB in ccRCC, indicating that TUBA1C participates in the occurrence and accumulation of mutations related to DNA repair and genome stability, thereby impacting outcomes and immune therapy responses in ccRCC patients (38). This evidence concerns the gene TUBA1C and nonpapillary renal cell carcinoma.